| Income Statement | 2025-09-30 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
| Net income allocated to preferred stockholders | 0 | -690,467 | - | - |
| Provision for income taxes | 0 | - | - | - |
| Total revenue-Product | 0 | - | - | - |
| Total revenue-Service | 0 | - | - | - |
| Total revenue-Listing Sponsorship Services | 0 | - | - | - |
| Total revenue | 0 | - | 28,000 | 168,149 |
| Cost of products sold | 0 | - | -41,600 | - |
| Cost of services | 0 | - | - | 1,575 |
| Research and development, net | 0 | 488 | 22,964 | 25,856 |
| General and administrative | 701,915 | 768,551 | 1,568,619 | 1,684,151 |
| Cost of products sold | - | - | - | 73,236 |
| Sales and marketing | 270 | 14,846 | 25,327 | 128,646 |
| Total operating expenses | 702,185 | 783,885 | 1,575,310 | 1,913,464 |
| Operating (loss) income | -702,185 | -783,885 | -1,547,310 | -1,745,315 |
| Gain on impairment adjustment | 0 | - | - | 2,079,575 |
| Gain on extinguishment of debt | 0 | 9,738,487 | - | - |
| Gain on settlement of compensation expenses | 0 | 570,785 | - | - |
| Change in fair value of eib loan guaranty | 0 | 683,200 | 178,802 | 46,584 |
| Foreign currency transaction (losses) gains | 0 | -2 | 184 | 281 |
| Interest and other income | 97,371 | 92,131 | 150,658 | 10 |
| Interest expense | 3,916 | 3,238 | 1,079 | - |
| Total other income (expense) | 93,455 | 9,714,963 | -29,039 | 2,033,282 |
| (loss) income before income taxes | -608,730 | 8,931,078 | -1,576,349 | 287,967 |
| Net (loss) income | -608,730 | 8,931,078 | -1,576,349 | 287,967 |
| Net income (loss) allocated to preferred stockholders | - | - | - | -84,462 |
| Net (loss) income available to common stockholders | -608,730 | 8,240,611 | -1,576,349 | 203,505 |
| Basic & diluted average shares | - | - | 1,340,285 | - |
| Basic | -0.06 | 1.43 | - | 0.158 |
| Basic | 10,071,286 | 5,760,214 | - | 1,284,305 |
| Diluted | -0.06 | 1.35 | - | 0.154 |
| Diluted | 10,071,286 | 6,603,804 | - | 1,331,578 |
OPGEN INC (OPGN)
OPGEN INC (OPGN)